₹1,650.8
▲ +138.35 +9.15%
16 Jun 2026
BSE Listed · Healthcare
Poly Medicure Ltd. (531768)
Volume: 6,858Avg Vol 1W: 12,107Avg Vol 1M: 15,03952W Range:₹1,182₹2,582.8
Key Ratios
Updated just nowMarket Cap₹15,520 Cr
Current Price₹1,650.8
Previous Close₹1,512.45
High / Low (52w)₹2,582.8 / ₹1,182
Volume6,858
Avg Vol (1W)12,107
Avg Vol (1M)15,039
Stock P/E67.11
Book Value₹306.45
Dividend Yield0.23%
ROE10.37%
ROA8.18%
Revenue (TTM)—
Revenue Growth21.37%
Profit Margin17.18%
Total Debt₹0 Cr
Shares Outstanding10 Cr
Face Value₹5
EPS (TTM)₹6.54
P/B5.39
Debt / Equity0.11
50 DMA₹1,480.16
200 DMA₹1,669.75
Day change+9.15%
Price Chart
₹1,515.6▼ 29.71% · 1Y
2025-06-172026-06-16
20-day avg volume: 16K shares
Pros
- Company is almost debt-free.
- Revenue grew 23% YoY.
- Net profit is growing year over year.
Cons
- Stock trades at a high P/E of 67.
Quarterly Results
| Metric | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sept 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sept 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sept 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sept 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹535 Cr | ₹494 Cr | ₹444 Cr | ₹403 Cr | ₹441 Cr | ₹424 Cr | ₹420 Cr | ₹385 Cr | ₹378 Cr | ₹340 Cr | ₹337 Cr | ₹321 Cr | ₹307 Cr | ₹285 Cr | ₹275 Cr | ₹249 Cr | ₹258 Cr | ₹230 Cr | ₹223 Cr | ₹212 Cr | ₹213 Cr | ₹204 Cr | ₹200 Cr | ₹170 Cr | ₹171 Cr |
| EBITDA | ₹90 Cr | ₹109 Cr | ₹124 Cr | ₹125 Cr | ₹123 Cr | ₹115 Cr | ₹121 Cr | ₹101 Cr | ₹95 Cr | ₹91 Cr | ₹82 Cr | ₹85 Cr | ₹77 Cr | ₹71 Cr | ₹59 Cr | ₹37 Cr | ₹50 Cr | ₹45 Cr | ₹50 Cr | ₹53 Cr | ₹48 Cr | ₹50 Cr | ₹48 Cr | ₹38 Cr | ₹36 Cr |
| Net Profit | ₹66 Cr | ₹71 Cr | ₹92 Cr | ₹93 Cr | ₹92 Cr | ₹85 Cr | ₹87 Cr | ₹74 Cr | ₹68 Cr | ₹65 Cr | ₹62 Cr | ₹63 Cr | ₹59 Cr | ₹50 Cr | ₹44 Cr | ₹27 Cr | ₹36 Cr | ₹35 Cr | ₹38 Cr | ₹38 Cr | ₹39 Cr | ₹35 Cr | ₹35 Cr | ₹27 Cr | ₹23 Cr |
| EPS | 6.53 | 6.99 | 9.06 | 9.17 | 8.92 | 8.48 | 9.01 | 7.71 | 7.12 | 6.77 | 6.47 | 6.53 | 6.13 | 5.2 | 4.53 | 2.81 | 3.77 | 3.6 | 3.98 | 3.92 | 4.25 | 3.99 | 3.96 | 3.03 | 2.57 |
Profit & Loss (Annual)
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Revenue | ₹1,759 Cr | ₹1,435 Cr | ₹1,151 Cr | ₹961 Cr | ₹805 Cr | ₹706 Cr |
| EBITDA | ₹459 Cr | ₹353 Cr | ₹244 Cr | ₹197 Cr | ₹185 Cr | ₹142 Cr |
| Net Profit | ₹339 Cr | ₹258 Cr | ₹179 Cr | ₹147 Cr | ₹136 Cr | ₹96 Cr |
| EPS | 34.11 | 26.9 | 18.67 | 15.27 | 15.24 | 10.86 |
Balance Sheet
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Total Assets | ₹3,192 Cr | ₹1,859 Cr | ₹1,577 Cr | ₹1,377 Cr | ₹1,224 Cr | ₹767 Cr |
| Total Liabilities | ₹427 Cr | ₹389 Cr | ₹336 Cr | ₹289 Cr | ₹258 Cr | ₹333 Cr |
| Equity | ₹2,766 Cr | ₹1,470 Cr | ₹1,242 Cr | ₹1,087 Cr | ₹966 Cr | ₹435 Cr |
| Total Debt | ₹0 Cr | ₹1 Cr | ₹18 Cr | ₹38 Cr | ₹63 Cr | ₹111 Cr |
Cash Flow
| Metric | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
| Operating | ₹333 Cr | ₹340 Cr | ₹249 Cr | ₹171 Cr | ₹163 Cr | ₹166 Cr |
| Investing | ₹-1,194 Cr | ₹-241 Cr | ₹-179 Cr | ₹-85 Cr | ₹-436 Cr | ₹-109 Cr |
| Financing | ₹951 Cr | ₹-20 Cr | ₹-13 Cr | ₹-35 Cr | ₹317 Cr | ₹-21 Cr |
| Free Cash Flow | ₹333 Cr | ₹340 Cr | ₹249 Cr | ₹171 Cr | ₹163 Cr | ₹166 Cr |
Shareholding
Promoter 62.42% Institutions 21.5% Public 16.08%
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search